Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
All probiotics studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchProbioticsProbiotics (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Recovery 51% Improvement Relative Risk Probiotics  Neris Almeida Viana et al.  META ANALYSIS c19early.org Favors probiotics Favors control

Benefits of probiotic use on COVID-19: A systematic review and meta-analysis

Neris Almeida Viana et al., Critical Reviews in Food Science and Nutrition, doi:10.1080/10408398.2022.2128713
Sep 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Probiotics for COVID-19
17th treatment shown to reduce risk in March 2021
 
*, now known with p = 0.0000013 from 26 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Systematic review and meta analysis showing significant improvement in symptoms with priobiotic treatment.
2 meta analyses show significant improvements with probiotics for hospitalization Tian and recovery Neris Almeida Viana, Tian.
Currently there are 26 probiotics for COVID-19 studies, showing 61% lower mortality [37‑76%], 38% lower ventilation [-87‑79%], 21% lower ICU admission [-20‑48%], 13% lower hospitalization [5‑21%], and 40% fewer cases [10‑60%].
risk of no recovery, 51.0% lower, RR 0.49, p < 0.001, symptoms.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Neris Almeida Viana et al., 30 Sep 2022, peer-reviewed, 7 authors.
This PaperProbioticsAll
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit